Bottom line
MEDI vs PRHSX: the short answer
MEDI (Harbor Health Care ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) share a meaningful slice of their top holdings — about 44% by weight.
But PRHSX is far broader, holding 279 positions to 44 for MEDI, so beyond the top names it adds exposure MEDI doesn't have.
MEDI is cheaper at 0.8% vs 0.83% — a difference of $3.00 a year per $10,000 invested.
Over one year, MEDI returned +27.1% vs +17.7% for PRHSX.
Updated Nov 19, 2026
MEDI vs PRHSX side by side
| MEDI | PRHSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Oakmark (Harris) | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.8% | 0.83% |
| Annual cost per $10k | $80 | $83 |
| 10-yr cost on $10k (prospectus) | $990 | $1,025 |
| Max front load | None | — |
| 12b-1 fee | 0% | — |
| 1-yr return | +27.1% | +17.7% |
| 5-yr return (annualized) | — | +4.2% |
| 10-yr return (annualized) | — | +9.1% |
| Best quarter | +14.4% | +23.5% |
| Worst quarter | −10.9% | −15.8% |
| Net assets (fund) | $41.2M | $11.9B |
| Number of holdings | 44 | 279 |
| Portfolio turnover | 167% | 62% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | MEDI | PRHSX | Difference |
|---|---|---|---|
| 2025 | +27.1% | +17.7% | +9.4% |
| 2024 | +0.5% | +1.8% | −1.3% |
| 2023 | +24.8% | +3.1% | +21.7% |
Source: Fund prospectus bar charts
Holdings overlap
10 of MEDI's top 25 holdings also appear in PRHSX's top 25.
| Holding | MEDI | PRHSX |
|---|---|---|
| Eli Lilly & Co | 20.78% | 14.28% |
| Gilead Sciences Inc | 5.10% | 2.82% |
| AbbVie Inc | 3.09% | 5.10% |
| Intuitive Surgical Inc | 2.83% | 1.87% |
| Merck & Co Inc | 2.47% | 4.01% |
| Natera Inc | 2.26% | 1.44% |
| Danaher Corp | 1.73% | 1.43% |
| Guardant Health Inc | 1.54% | 1.23% |
| UnitedHealth Group Inc | 1.39% | 5.99% |
| Vertex Pharmaceuticals Inc | 1.22% | 2.28% |
Source: SEC Form N-PORT
MEDI top 10
- Eli Lilly & Co — 20.78%
- Ascendis Pharma A/S — 13.61%
- Gilead Sciences Inc — 5.10%
- Rhythm Pharmaceuticals Inc — 4.02%
- AbbVie Inc — 3.09%
- Intuitive Surgical Inc — 2.83%
- Cencora Inc — 2.75%
- Revolution Medicines Inc — 2.54%
- Insmed Inc — 2.52%
- Merck & Co Inc — 2.47%
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FAQ
What is the difference between MEDI and PRHSX?
Which is cheaper, MEDI or PRHSX?
Should I own both MEDI and PRHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.